What is the relationship between marijuana and mental health? All of them. After all, marijuana has been proven to help with depression and many other illnesses. Over 300 million people worldwide suffer from depression. Another 300 million people suffer from some form of anxiety, and according to the United Nations, depression is the leading cause of death by suicide. Given the conditions that cause mental illness, marijuana is emerging as a therapeutic alternative. Researchers are working to understand how cannabinoids act on the brain and help treat mental illnesses and disorders by providing therapeutic effects and mitigating the side effects of antagonistic medications. Moreover, you can keep marijuana in custom marijuana packaging to keep it safe.
According to the World Health Organization (WHO), 11.5 million people are depressed in the US, representing almost 6% of the population. The number of patients with anxiety disorders is even higher, at 18.6 million, representing just over 9% of the national population. The report also states that depression is exacerbated by life conditions such as poverty, unemployment, death of relatives or friends, broken relationships, physical fatigue, and problems caused by substance abuse.
The pandemic has exacerbated anxiety worldwide, including the emergence of a new disorder called “colonophobia,” characterized by an excessive, persistent and unrealistic fear of situations, people, and objects, first described in a study published in the Asian Journal of Psychiatry in December 2020.
Phobias are also known as anxiety disorders, obsessive-compulsive disorders, panic attacks, post-traumatic stress disorder (PTSD), and generalized anxiety.
American researchers conducted a study in 2015 to investigate the therapeutic potential of CBD (cannabidiol) for anxiety disorders. The study provided preclinical evidence that the substance reduces anxious behavior. In addition, CBD did not cause the physical and psychological distress often seen with treatment with allopathic drugs.
A study conducted on healthy volunteers, animals, and patients with anxiety disorders concluded that cannabidiol has anxiolytic effects, does not contribute to psych activity, and does not affect cognition.
It’s worth remembering that research has shown the importance of treating anxiety with marijuana products low in THC and high in CBD.
According to the World Health Organization (WHO), 12 million people suffer from depression in the US alone. And marijuana is proving to be a promising option in the fight against this disease. Researchers from the University of São Paulo, Ribeirao Preto (FMRP), based on studies and literature reviews on the therapeutic use of cannabinoids in psychiatry, reviewed the main developments in the potential therapeutic use of some cannabinoid compounds. He links marijuana plants and mental health.
The review showed that cannabidiol has potential therapeutic effects as an antipsychotic, anxiolytic, and antidepressant. Scientists from the University of New Mexico also studied the direct effects of using natural marijuana flowers or “buds” to treat symptoms of depression.
This information was collected through the “Releaf” mobile app, which records changes in symptom intensity and side effects in real time and helps manage herbal intake. Data from 1,819 people who used the app to self-administer 5,876 marijuana treatments were analyzed. The results showed that 95.8% of users experienced relief from depressive symptoms after using the app. It was, therefore, suggested that most marijuana users experience at least short-term antidepressant effects. Moreover, most people using cannabis keep it in custom marijuana packaging.
PTSD (Post-Traumatic Stress Disorder)
PTSD is a chronic illness that can last for years or even a lifetime. It is characterized by difficulty in freeing oneself from the traumatic events experienced or witnessed. Each time the patient refers to this memory, a strong emotional or physical reaction is triggered, but the trigger can also be a banal event in everyday life.
In addition to psychotherapy, the most common treatment method today is the use of opioids, which are addictive and even deadly – a widely accepted scenario in the United States. Between 1999 and 2017, the U.S. Centers for Disease Control and Prevention recorded more than 218,000 deaths from opioid use.
Its use and abuse have been linked to its remarkable effectiveness in relieving pain and minimizing depression and anxiety, in addition to treating co-existing experiences and trauma, particularly among veterans suffering from physical pain due to injuries sustained in combat, a widespread condition.
These individuals have found mainly CBD (cannabidiol) alternatives that ultimately relieve their pain and trauma without the risks associated with allopathic drugs and the mental health issues associated with cannabidiol. The researchers demonstrated “the pioneering role of CBD in alleviating cognitive impairment caused by traumatic memories, through a mechanism by which CBD can mediate the refreezing of traumatic memories.”
Nightmares are Another Common Symptom in PTSD Patients
Canadian researchers conducted a preliminary randomized, double-blind, placebo-controlled crossover study to determine the efficacy of the synthetic cannabinoid nabilone in treating nightmares associated with this condition. Canadian Forces soldiers with PTSD participated in the study.
The conclusion was that the compound “provided significant relief to military personnel with PTSD, suggesting that it is a promising and clinically important treatment for nightmare patients who do not respond to conventional treatments.”
In summary, this study demonstrates the therapeutic potential of marijuana and the mental health benefits of its use in patients with various types of mental disorders and illnesses. Try custom cbd packaging to keep cannabis for the use of patients.